Recombinant Anti-human TLR9 Intrabody [Tat] (CAT#: IAB-B043(T))

• Immunogen
• human Toll-like receptor 9

• Host Species
• human

• Type
• scFv-Tat

• Cell Penetrating Peptide
• TAT
  TAT was able to deliver different proteins, such as horseradish peroxidase and RNase A across cell membrane into the cytoplasm in different cell lines in vitro. The size range of proteins with effective delivery is from 30kDa to 120-150kDa. In one study, TAT-fused proteins are rapidly internalized by lipid raft−dependent macropinocytosis using a transducible TAT−Cre recombinase reporter assay on live cells. In another study, a TAT-fused protein was delivered into mitochondria of breast cancer cells and decreased the survival of breast cancer cells, which showed capability of TAT-fusion proteins to modulate mitochondrial function and cell survival. However, very few in vivo studies have succeeded. In one study, in vivo delivery of TAT- or penetratin-crosslinked Fab fragments yielded varied organ distributions and an overall increase in organ retention, which showed tissue localization.

• Species Reactivity
• human

• Applications
• Formats of immunological tests: Protein fragment complementation; Neutralization; Functional studies

• Purity
• >95% as determined by analysis by SDS-PAGE

• Storage
• ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C

• Alternative Names
• TLR9; toll-like receptor 9; CD289

• Gene ID
• 54106

• UniProt ID
• Q9NR96

Select a product category from the dropdown menu below to view related products.